{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:27Z","timestamp":1790996787683,"version":"4.1.0"},"reference-count":30,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.7883\/yoken.jjid.2022.210","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T22:17:51Z","timestamp":1659046671000},"page":"592-596","source":"Crossref","is-referenced-by-count":7,"title":["The Relationship between Clinical Findings and Viral Load in Adenoviral Keratoconjunctivitis"],"prefix":"10.7883","volume":"75","author":[{"given":"Puren","family":"Isik","sequence":"first","affiliation":[{"name":"Ophthalmology Department, Faculty of Medicine, Balcali Hospital, Cukurova University, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Inan","family":"Harbiyeli","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Faculty of Medicine, Balcali Hospital, Cukurova University, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Virology Department, Faculty of Medicine, Cukurova University, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Erdem","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Faculty of Medicine, Balcali Hospital, Cukurova University, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Yagmur","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Faculty of Medicine, Balcali Hospital, Cukurova University, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fugen","family":"Yarkin","sequence":"additional","affiliation":[{"name":"Virology Department, Faculty of Medicine, Cukurova University, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Varu DM, Rhee MK, Akpek EK, et al. Conjunctivitis preferred practice pattern. Ophthalmol. 2019;126: 94-169.","DOI":"10.1016\/j.ophtha.2018.10.020"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kuo IC. Adenoviral keratoconcunjtivitis: diagnosis, management, and prevention. Curr Ophthalmol Rep. 2019;7:118-127.","DOI":"10.1007\/s40135-019-00207-y"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Butt AL, Chodosh J. Adenoviral keratoconjunctivitis in a tertiary care eye clinic. Cornea. 2006;25:199-202.","DOI":"10.1097\/01.ico.0000170693.13326.fb"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kaufman HE. Adenovirus advances: new diagnostic and therapeutic options. Curr Opin Ophthalmol. 2011;22:290-293.","DOI":"10.1097\/ICU.0b013e3283477cb5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jhanji V, Chan TC, Li EY, et al. Adenoviral keratoconjunctivitis. Surv Ophthalmol. 2015;60:435-443.","DOI":"10.1016\/j.survophthal.2015.04.001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. De Cock R. Membranous, pseudomembranous and ligneous conjunctivitis. Dev Ophthalmol. 1997; 28:32-45.","DOI":"10.1159\/000060697"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Butt AL, Chodosh J. Adenoviral keratoconjunctivitis in a tertiary care eye clinic. Cornea. 2006;25:199-202.","DOI":"10.1097\/01.ico.0000170693.13326.fb"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Akal A, O\u011fuz H. Conjunctivitis. Turk J Ophthalmol. 2012;42:48-51.Turkish.","DOI":"10.4274\/tjo.42.s10"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shorter E, Whiteside M, Harthan J, et al. Safety and tolerability of a one-time, in-office administration of 5% povidone-lodine in the treatment of adenoviral conjunctivitis: the reducing adenoviral patient infected days (RAPID) study. Ocul Surf. 2019;17:828-832.","DOI":"10.1016\/j.jtos.2019.08.005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pepose JS, Ahuja A, Liu W, et al. Randomized, controlled, phase 2 trial of povidone-Iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis. Am J Ophthalmol. 2018;194:7-15.","DOI":"10.1016\/j.ajo.2018.05.012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kovalyuk N, Kaiserman I, Mimouni M, et al. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol. 2017; 95:e686-e692.","DOI":"10.1111\/aos.13416"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Pinto RD, Lira RP, Abe RY, et al. Dexamethasone \/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial. Curr Eye Res. 2015;40:870-877.","DOI":"10.3109\/02713683.2014.964419"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pelletier JS, Stewart K, Trattler W, et al. A combination povidone-iodine 0.4%\/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Adv Ther. 2009;26:776-783.","DOI":"10.1007\/s12325-009-0062-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pepose JS, Narvekar A, Liu W, et al. A randomized controlled trial of povidone-iodine\/dexamethasone ophthalmic suspension for acute viral conjunctivitis. Clin Ophthalmol. 2019;13:535-544.","DOI":"10.2147\/OPTH.S191275"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dang RM, Watt K, Hui A. Povidone iodine for the treatment of conjunctivitis. Clin Exp Optom. 2021;104:308-314.","DOI":"10.1080\/08164622.2021.1877532"},{"key":"16","unstructured":"16. Abelson MB, Shapiro A. A guide to understanding adenovirus, the diseases it causes and the best ways to treat these conditions. Available at <https:\/\/www.reviewofophthalmology.com\/article\/a-guide-to-understanding-adenovirus-the-diseases-it-causes-and-the-best-ways-to-treat-these-conditions>. Accessed March, 2010."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Goikhman Y, Drori Y, Friedman N, et al. Adenovirus load correlates with respiratory disease severity among hospitalized pediatric patients. Int J Infect Dis. 2020;97:145-150.","DOI":"10.1016\/j.ijid.2020.06.010"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Xie L, Zhang B, Zhou J, et al. Human adenovirus load in respiratory tract secretions are predictors for disease severity in children with human adenovirus pneumonia. Virol J. 2018; 15:123.","DOI":"10.1186\/s12985-018-1037-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Arici C, Sultan P, Mergen B, et al. The impact of bilateral subepithelial corneal infiltrates on tear film after epidemic keratoconjunctivitis. Eye Contact Lens. 2020;46: 281-284.","DOI":"10.1097\/ICL.0000000000000678"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hammer LH, Perry HD, Donnenfeld ED, et al. Symblepharon formation in epidemic keratoconjunctivitis. Cornea. 1990;9:338-340.","DOI":"10.1097\/00003226-199010000-00013"},{"key":"21","unstructured":"21. Tabbara KF, Omar N, Hammouda E, et al. Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia. Mol Vis. 2010;16:2132-2136."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. de-Arriba-Palomero F, Salv\u00e1-Palomeque T, de-Arriba-Palomero P, et al. Epidemiology of pseudomembranous conjunctivitis in a tertiary hospital: a 2-year retrospective study. Eur J Ophthalmology. 2021;31:2275-2279.","DOI":"10.1177\/1120672120957581"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Dosso AA, Rungger-Br\u00e4ndle E. Clinical course of epidemic keratoconjunctivitis: evaluation by in vivo confocal microscopy. Cornea. 2008;27:263-268.","DOI":"10.1097\/ICO.0b013e31815b7d7d"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lund OE, Stefani FH. Corneal histology after epidemic keratoconjunctivitis. Arch Ophthalmol. 1978;96:2085-2088.","DOI":"10.1001\/archopht.1978.03910060465016"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lee CS, Lee AY, Akileswaran L, et al. Determinants of outcomes of adenoviral keratoconjunctivitis. Ophthalmology. 2018;125:1344-1353.","DOI":"10.1016\/j.ophtha.2018.02.016"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Garcia-Zalisnak D, Rapuano C, Sheppard JD, et al. Adenovirus ocular infections: prevalence, pathology, pitfalls, and practical pointers. Eye Contact Lens. 2018;44:S1-S7.","DOI":"10.1097\/ICL.0000000000000226"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Gonz\u00e1lez-L\u00f3pez JJ, Morcillo-Laiz R, Mu\u00f1oz-Negrete FJ. Adenoviral keratoconjunctivitis: an update. Arch Soc Esp Oftalmol. 2013;88:108-115.","DOI":"10.1016\/j.oftale.2012.07.002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Trousdale MD, Nesburn AB, Willey DE, et al. Efficacy of BW759 (9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine) against herpes simplex virus type 1 keratitis in rabbits. Curr Eye Res. 1984;3:1007-1015.","DOI":"10.3109\/02713688409011747"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ying B, Tollefson AE, Spencer JF, et al. Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed syrian hamsters. Antimicrob Agents Chemother. 2014;58:7171-7181.","DOI":"10.1128\/AAC.03860-14"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Matsuura K, Terasaka Y, Miyazaki D, et al. Quantitative investigation of viral load in acute to subacute human adenovirus type 54 conjunctivitis. Jpn J Infect Dis. 2021;74:567-569.","DOI":"10.7883\/yoken.JJID.2020.1019"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/6\/75_JJID.2022.210\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T04:10:23Z","timestamp":1669435823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/6\/75_JJID.2022.210\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2022.210","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"article-number":"JJID.2022.210"}}